Pharmafile Logo
Pharmafocus logo
Advanced Search

trials

Showing 15 posts of 16 posts found.

Novartis report longest median OS in breast cancer study

June 3, 2021
Novartis, breast cancer, trials

Novartis has announced updated median overall survival (OS) results for Kisqali (ribociclib), in combination with fulvestrant, in postmenopausal women with …

News
celgene_building

Celgene’s Abraxane combo flops in phase 3 cancer trials

March 14, 2019
Research and Development Abraxane, Celgene, clinical trials, pharma, trials

Celgene’s Abraxane, in combination gemcitabine, has failed to meet its primary endpoint in a pivotal Phase 3 trial of patients …

News

AMAG Pharmaceuticals’ shares fall 21% after failed Makena trial

March 11, 2019
Sales and Marketing AMAG Pharmaceuticals, Makena, PROLONG, birth, trials

AMAG Pharmaceuticals’ Makena (hydroxyprogesterone caproate) has failed to meet its co-primary endpoints in a trial of patients with a history …

News
920x920

OxyContin drugmaker Purdue Pharma exploring bankruptcy, sources say

March 4, 2019
Manufacturing and Production Litigation, Purdue Pharma, bankruptcy, opioid crisis, trials

OxyContin drugmaker Purdue Pharma is exploring the option of filing for bankruptcy. The news comes as the Connecticut-based firm faces …

News

Stem cells could ‘reset’ immune system in Crohn’s disease patients

August 8, 2018
Research and Development Crohn’s disease, Stem cells, crohn's disease, trials

A clinical trial led by researchers at Queen Mary University, London is looking into ways in which patients with Crohn’s …

News
aedes_aegypti_mosquito

First-in-man Zika vaccine trials get green light

June 21, 2016
Manufacturing and Production, Research and Development trials, zika vaccine

Inovio Pharmaceuticals (NASDAQ: INO) and GeneOne Life Science (KSE: 011000) have announced that approval has been granted for the commencement …

News
Science image

Drug development contracts: can lessons be learned from healthcare delivery?

March 16, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, CRO, Les Rose, NHS, drug development, trials

There is a very good question to ask at the beginning of every project: “What does success look like?” If …

Feature
servier image

Servier slammed over UK trial transparency failure

September 8, 2014
Medical Communications, Research and Development, Sales and Marketing ABPI, PMCPA, Servier, code, conduct, transparancy, trials

Servier has been found guilty of the most serious breach of the UK’s pharma code of conduct after failing to …

News
Lilly image

Lilly the latest to open up data

June 4, 2014
Medical Communications, Research and Development, Sales and Marketing Goldacre, NHS, alltrials, data, lilly, transparency, trials

Eli Lilly is to begin sharing its clinical trial data with scientific researchers through a website housing information from several …

News
EMA image

EMA launches speedy pilot

March 21, 2014
Sales and Marketing BIA, EMA, MHRA, NICE, early access, trials

The European Medicines Agency (EMA) has launched an initiative aimed at speeding up the drug approval process and wants help …

News
Blood pressure image

Look beyond the screen

March 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, cliinical, data, screening, trials

It makes sense, doesn’t it? You have a drug that’s effective for a certain disease, but no patients. What do …

Feature

Unpublished trials ‘violates ethical obligation’ to patients

October 30, 2013
Research and Development, Sales and Marketing BMJ, Goldacre, all trials, trials

A new study published in the BMJ has found almost one in three (29%) of large clinical trials remain unpublished …

News
NICE image

Grant NICE greater trial data access – report

May 29, 2013
Research and Development, Sales and Marketing Goldacre, NICE, transparency, trials

A new report by the National Audit Office says NICE should be given greater powers to access clinical trial data. …

News
Novartis image

Novartis R&D warning

November 29, 2012
Research and Development, Sales and Marketing NHS, Novartis. R&D, trials

Novartis has hit out at what it sees as the high cost of UK clinical trials, warning that business will …

News

EFPIA rejects ‘indiscriminate’ transparency

November 16, 2012
Medical Communications, Research and Development, Sales and Marketing EFPIA, Goldacre, transparency, trials

Europe’s pharma trade body has poured tepid water on the idea of open access to clinical trial data, saying that …

News

Latest content

Regeneron and Mammoth Biosciences announce CRISPR collaboration

April 26, 2024

ANGLE signs commercial agreement with AstraZeneca

April 26, 2024

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024